Long circulating photoactivable nanomicelles with tumor localized activation and ROS triggered self-accelerating drug release for enhanced locoregional chemo-photodynamic therapy

Biomaterials. 2020 Feb:232:119702. doi: 10.1016/j.biomaterials.2019.119702. Epub 2019 Dec 26.

Abstract

Although chemo-photodynamic therapy demonstrates promising synergetic therapeutic effect in malignant cancers, the currently available nanocarriers offer the limited capabilities for selective toxicity, drug release and tumor penetration. Herein, we developed photoactivatable nanomicelles, which are constructed by self-assembling of poly (ethylene glycol) (PEG)-stearamine (C18) conjugate (PTS) with a ROS-sensitive thioketal linker (TL) and co-loaded with doxorubicin (DOX) and photosensitizer pheophorbide A (PhA), for enhanced locoregional chemo-photodynamic therapy. Upon accumulation in tumor region, the resulting PTS nanomicelles loaded with Dox and PhA (PTS-DP) demonstrated reactive oxygen species (ROS) cascade responsive release of the DOX and PhA loaded inside. Initial intracellular release of DOX and PhA from the PTS-DP was triggered by the intrinsic presence of endogenous ROS within cancer cells. Furthermore, upon laser irradiation on the tumor region, enhanced singlet oxygen (1O2) was generated by PhA released initially in cancer cells, which in turns accelerated the cytoplasmic release of DOX through rapid dissociation of nanomicelles. The gradual elevation of local ROS level generated by light-activated PhA subsequent ROS-triggered release of DOX synergistically inhibited tumor growth and enhances the anti-tumor immunity. Findings of our study suggested that ROS-sensitive PTS nanomicelles could be a promising and innovative nanocarrier for locoregional chemo-photodynamic therapy.

Keywords: Antitumor immunity; Locoregional chemo-photodynamic therapy; Nanomicelles; Photoactivable; ROS sensitive linker.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Doxorubicin
  • Drug Liberation*
  • Nanoparticles*
  • Neoplasms / therapy
  • Photochemotherapy*
  • Photosensitizing Agents
  • Reactive Oxygen Species*

Substances

  • Photosensitizing Agents
  • Reactive Oxygen Species
  • Doxorubicin